Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance
by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl
Updated on: May 27,2024
3
Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance
by Sharita Forrest,University of Illinois at Urbana-ChampaignTargeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneousl
Updated on:May 27,2024
3